{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:31:11Z","timestamp":1786681871647,"version":"build-2736575974"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To explore a gantry-period-guided strategy for identifying a lower useful modulation factor (MF) in helical tomotherapy under fixed field width and pitch.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty previously treated cases from head, head-and-neck, abdomen and pelvis were replanned with a field width of 2.5\u00a0cm and a pitch of 0.287. MF was initialized at 5.0 and reduced by 0.2 with unchanged objectives. At each level, plans were reoptimized and clinically reviewed. MF\n                      <jats:sub>limit<\/jats:sub>\n                      was defined as the last clinically acceptable MF before the step-down sequence entered the mechanical gantry-period plateau (~11.8 s); MF\n                      <jats:sub>min<\/jats:sub>\n                      was the lowest clinically acceptable MF identified after further reduction. Gantry period, delivery time, leaf-open-time (LOT) metrics, dosimetric indices and pretreatment gamma pass rates were compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All cases entered the efficiency-limited pathway. MF\n                      <jats:sub>limit<\/jats:sub>\n                      ranged from 1.9 to 2.8. MF reduction produced a biphasic gantry-period response, with an initial decrease followed by a mechanical plateau. Further reduction from MF\n                      <jats:sub>limit<\/jats:sub>\n                      to MF\n                      <jats:sub>min<\/jats:sub>\n                      did not meaningfully reduce delivery time. LOT\n                      <jats:sub>max<\/jats:sub>\n                      decreased and LOT\n                      <jats:sub>mean<\/jats:sub>\n                      remained relatively stable, whereas T\n                      <jats:sub>gap<\/jats:sub>\n                      , defined as the temporal gap between the available projection time and LOT\n                      <jats:sub>max<\/jats:sub>\n                      , increased markedly at MF\n                      <jats:sub>min<\/jats:sub>\n                      , indicating unused projection time after plateau entry. Compared with MF\n                      <jats:sub>min<\/jats:sub>\n                      , MF\n                      <jats:sub>limit<\/jats:sub>\n                      was associated with improved PTV homogeneity and conformity, more favorable exploratory pooled OAR dose trends, and higher 1%\/1\u00a0mm gamma pass rates, while 3%\/2\u00a0mm and 2%\/2\u00a0mm pass rates were similar.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The MF immediately before gantry-period plateau entry may provide a practical reference point for limiting MF reduction. In this pilot cohort, this gantry-period-guided approach helped maintain plan quality and avoid reductions in modulation that offered little efficiency benefit. Further studies across additional planning configurations and disease sites will be needed to confirm its broader applicability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1891272","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:23:38Z","timestamp":1786681418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gantry-period-guided modulation factor selection in helical tomotherapy: effects on delivery efficiency, dosimetry and verification accuracy"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoli","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Equipment Management and Maintenance Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1118\/1.596958","article-title":"Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy","volume":"20","author":"Mackie","year":"1993","journal-title":"Med Phys"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rry042","article-title":"Interfacility variation in treatment planning parameters in tomotherapy: field width, pitch, and modulation factor","volume":"59","author":"Shimizu","year":"2018","journal-title":"J Radiat Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_393_21","article-title":"Dosimetric and delivery comparison of helical tomotherapy with dynamic jaw and fixed jaw for cervical carcinoma","volume":"17","author":"Wu","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1118\/1.1896453","article-title":"The helical tomotherapy thread effect","volume":"32","author":"Kissick","year":"2005","journal-title":"Med Phys"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1118\/1.3644842","article-title":"Theoretical analysis of the thread effect in helical TomoTherapy","volume":"38","author":"Chen","year":"2011","journal-title":"Med Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1118\/1.2748105","article-title":"Quality assurance of the multileaf collimator with helical tomotherapy: design and implementation","volume":"34","author":"Sarkar","year":"2007","journal-title":"Med Phys"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33390","DOI":"10.1038\/s41598-025-18445-5","article-title":"A case study on optimizing helical tomotherapy parameters for small cell lung cancer with extensive pleural metastasis","volume":"15","author":"Duan","year":"2025","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.4.1239","article-title":"Optimal combination of pitch, modulation factor and dosimetric considerations in treatment planning for total body irradiation using helical tomotherapy","volume":"24","author":"Kaliyaperumal","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2012.03.007","article-title":"Optimization of treatment planning parameters used in tomotherapy for prostate cancer patients","volume":"29","author":"Sk\u00f3rska","year":"2013","journal-title":"Phys Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/jmp.JMP_31_20","article-title":"Evaluation of optimal combination of planning parameters (field width, pitch, and modulation factor) in helical tomotherapy for bilateral breast cancer","volume":"45","author":"Muthuselvi","year":"2020","journal-title":"J Med Phys"},{"key":"B11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/acm2.12581","article-title":"Determining efficient helical IMRT modulation factor from the MLC leaf-open time distribution on precision treatment planning system","volume":"20","author":"Boyd","year":"2019","journal-title":"J Appl Clin Med Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.12075","article-title":"Analysis of modulation factor to shorten the delivery time in helical tomotherapy","volume":"18","author":"Shimizu","year":"2017","journal-title":"J Appl Clin Med Phys"},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13014-015-0497-2","article-title":"Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts","volume":"10","author":"De Kerf","year":"2015","journal-title":"Radiat Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.004","article-title":"Treatment planning to improve delivery accuracy and patient throughput in helical tomotherapy","volume":"74","author":"Westerly","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.12895","article-title":"On the complexity of helical tomotherapy treatment plans","volume":"21","author":"Santos","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.93.supplement","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","volume":"93","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-011-0015-x","article-title":"The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)","volume":"188","author":"Hodapp","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/mp.12810","article-title":"Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218","volume":"45","author":"Miften","year":"2018","journal-title":"Med Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1891272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:23:39Z","timestamp":1786681419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1891272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":18,"alternative-id":["10.3389\/fonc.2026.1891272"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1891272","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1891272"}}